Annual Accounts Receivable:
$264.93M+$58.48M(+28.33%)Summary
- As of today, APLS annual accounts receivable is $264.93 million, with the most recent change of +$58.48 million (+28.33%) on December 31, 2024.
- During the last 3 years, APLS annual accounts receivable has risen by +$254.82 million (+2522.25%).
- APLS annual accounts receivable is now at all-time high.
Performance
APLS Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Accounts Receivable:
$345.54M+$131.41M(+61.37%)Summary
- As of today, APLS quarterly accounts receivable is $345.54 million, with the most recent change of +$131.41 million (+61.37%) on September 30, 2025.
- Over the past year, APLS quarterly accounts receivable has increased by +$66.53 million (+23.84%).
- APLS quarterly accounts receivable is now at all-time high.
Performance
APLS Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
APLS Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +28.3% | +23.8% |
| 3Y3 Years | +2522.3% | +4170.6% |
| 5Y5 Years | - | - |
APLS Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +3328.6% | at high | +4371.8% |
| 5Y | 5-Year | at high | >+9999.0% | at high | >+9999.0% |
| All-Time | All-Time | at high | >+9999.0% | at high | >+9999.0% |
APLS Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $345.54M(+61.4%) |
| Jun 2025 | - | $214.13M(-9.0%) |
| Mar 2025 | - | $235.25M(-11.2%) |
| Dec 2024 | $264.93M(+28.3%) | $264.93M(-5.0%) |
| Sep 2024 | - | $279.01M(-8.4%) |
| Jun 2024 | - | $304.43M(+13.7%) |
| Mar 2024 | - | $267.84M(+29.7%) |
| Dec 2023 | $206.44M | $206.44M(+22.0%) |
| Sep 2023 | - | $169.26M(+52.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $110.91M(+252.0%) |
| Mar 2023 | - | $31.50M(+307.7%) |
| Dec 2022 | $7.73M(-23.5%) | $7.73M(-4.5%) |
| Sep 2022 | - | $8.09M(+7.6%) |
| Jun 2022 | - | $7.52M(+18.8%) |
| Mar 2022 | - | $6.33M(-37.3%) |
| Dec 2021 | $10.10M(>+9900.0%) | $10.10M(+186.9%) |
| Sep 2021 | - | $3.52M(+389.8%) |
| Jun 2021 | - | $719.00K(>+9900.0%) |
| Dec 2020 | $0.00 | $0.00 |
FAQ
- What is Apellis Pharmaceuticals, Inc. annual accounts receivable?
- What is the all-time high annual accounts receivable for Apellis Pharmaceuticals, Inc.?
- What is Apellis Pharmaceuticals, Inc. annual accounts receivable year-on-year change?
- What is Apellis Pharmaceuticals, Inc. quarterly accounts receivable?
- What is the all-time high quarterly accounts receivable for Apellis Pharmaceuticals, Inc.?
- What is Apellis Pharmaceuticals, Inc. quarterly accounts receivable year-on-year change?
What is Apellis Pharmaceuticals, Inc. annual accounts receivable?
The current annual accounts receivable of APLS is $264.93M
What is the all-time high annual accounts receivable for Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. all-time high annual accounts receivable is $264.93M
What is Apellis Pharmaceuticals, Inc. annual accounts receivable year-on-year change?
Over the past year, APLS annual accounts receivable has changed by +$58.48M (+28.33%)
What is Apellis Pharmaceuticals, Inc. quarterly accounts receivable?
The current quarterly accounts receivable of APLS is $345.54M
What is the all-time high quarterly accounts receivable for Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. all-time high quarterly accounts receivable is $345.54M
What is Apellis Pharmaceuticals, Inc. quarterly accounts receivable year-on-year change?
Over the past year, APLS quarterly accounts receivable has changed by +$66.53M (+23.84%)